Biomea Fusion completes enrollment in Phase II diabetes trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/6/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Biomea Fusion completes enrollment in Phase II diabetes trial
(NASDAQ: BMEA) Delayed: 2.03 +0.12 (6.28%)
Previous Close $1.91    52 Week High $ 
Open $1.90    52 Week Low $ 
Day High $2.05    P/E N/A 
Day Low $1.89    EPS $ 
Volume 3,290,497